Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Contineum Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CTNM alerts

About Stephen L. Huhn

The proxy statement of Contineum Therapeutics, Inc. reports total compensation of $2,121,674 for Stephen L. Huhn in fiscal 2024, including a base salary of $485,403. Contineum Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Contineum Therapeutics, Inc. includes Carmine N. Stengone (CEO and Board Member), Peter T. Slover (CFO), John S. Healy (General Counsel) and 7 others.

Affiliation history

Company network

Leadership on record at Contineum Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Contineum Therapeutics, Inc. (CTNM) $485,403 $2,121,674

Recent activity

No call appearances or filed executive changes recorded yet.